North America Cardiac Assist Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Market is Segmented by Product (Intra-aortic Balloon Pumps, Total Artificial Heart, Ventricular Assist Devices) and Geography.

Market Snapshot

Picture The North America Cardiac Assist Devices Market
Study Period: 2018 - 2026
Base Year: 2020
CAGR: 8.1 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Continuous rapid advancements in the assist devices technologies and the novel applications of the existing treatments have led to an increase in the demand for cardiac assist devices. Other factors responsible for the market growth are lack of donor's hearts for transplantation, aging population, and increasing heart diseases. These factors are leading to an increase in the usage of cardiac assist devices implantations in patients with severe heart complications. As per the report from the American Heart Association on heart disease and stroke, in 2017, approximately 800,000 deaths were caused due to cardiovascular diseases. However, the availability of alternative treatments, like pacemakers, and the risk associated with device implantation are likely to impede the market for cardiac assist devices.

Scope of the Report

As per the scope of the report, assist devices are defined as the type of mechanical pumps that work along with the heart, to improve the pumping efficiency and maintain optimum blood flow throughout the body. Cardiac-assist devices are used to treat end-stage heart failure and are determined by the needs of the individual. They are of three types, namely, ventricular assist devices, intra-aortic balloon pumps (IABPs), and the total artificial heart.

By Product
Intra-aortic Balloon Pumps
Total Artificial Heart
Ventricular Assist Devices
Left Ventricular Assist Device
Right Ventricular Assist Device
Geography
North America
United States
Canada
Mexico

Report scope can be customized per your requirements. Click here.

Key Market Trends

Total Artificial Hearts Segment Dominates the North American Cardiac Assist Devices Market

Heart transplantation is the most effective treatment for end-stage heart failures. Unfortunately, the supply of donor's hearts does not meet the increasing demand. Many patients die while they are placed on the waiting list. Though there has been an increase in the demand for donor's hearts, the number of donor organs has been less. This has resulted in an exponential rise in the demand for artificial heart in the market. The total artificial heart is considered to be one of the best long-term solutions for patients suffering from advanced heart failure issues The various extracorporeal and ventricular assist devices can only be considered as temporary solutions. Some of the companies offering cardiac assist devices are Abbott Laboratories and Syncardia.

Cardiac Assist Device Trend.png

Competitive Landscape

The North American cardiac assist devices market is highly fragmented in nature, with the presence of many prominent players. Players are focusing on major collaborations, mergers, and acquisitions, in order to enhance their market share. Market players are also focusing on R&D to improve product quality and minimize manufacturing costs. Furthermore, they are developing safer devices to improve patient compliance and safety. Some of the top market players are Abiomed Inc., Abbott Laboratories, Medtronic, Syncardia, and Berlin Heart Gmbh, among others.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Heart Diseases

      2. 4.2.2 Advancements in Technology

      3. 4.2.3 Shortage of Heart Donors in Transplantation

    3. 4.3 Market Restraints

      1. 4.3.1 Risk Associated with Device Implantation

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Intra-aortic Balloon Pumps

      2. 5.1.2 Total Artificial Heart

      3. 5.1.3 Ventricular Assist Devices

        1. 5.1.3.1 Left Ventricular Assist Device

        2. 5.1.3.2 Right Ventricular Assist Device

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abiomed Inc.

      2. 6.1.2 Abbott Laboratories

      3. 6.1.3 Bioheart Inc.

      4. 6.1.4 Cardiac Assist Inc.

      5. 6.1.5 Calon Cardio-Technology Ltd

      6. 6.1.6 LivaNova PLC (Cardiac Assist Inc.)

      7. 6.1.7 Cardiokinetix Inc.

      8. 6.1.8 Medtronic Plc

      9. 6.1.9 SynCardia Systems LLC

      10. 6.1.10 ReliantHeart

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Cardiac Assist Devices Market market is studied from 2018 - 2026.

The North America Cardiac Assist Devices Market is growing at a CAGR of 8.1% over the next 5 years.

Abiomed Inc., Abbott Laboratories, Medtronic, (LivaNova PLC) CardiacAssist Inc., SynCardia Systems LLC are the major companies operating in North America Cardiac Assist Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!